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incisors: 17/89; canines: 16/88; premolars: 13/88; first and second molars: 10/89; third molars: 10/88.
Conclusion:
There are a number of surgeons who do not always administer a palatal injection for extraction of maxillary teeth under local anaesthetics. The number is greater for anterior compared to posterior teeth.
Introduction
Conventional teaching regarding local anaesthesia for the removal of maxillary teeth dictates that both a buccal and palatal injection (block and/or infiltration) are to be administered 1 .
Unfortunately, palatal injection is poorly tolerated by patients due to the rich nerve supply of the palatal tissues and firm attachment of palatal mucosa to bone [2] [3] [4] [5] . Recently, a number of authors have questioned the necessity of administering the palatal injection, suggesting that contemporary local anaesthetics might diffuse sufficiently across the buccal-palatal cortical bone distance. This distance increases anteriorly to posteriorly in the maxilla; therefore, the success of maxillary extractions performed with buccal injection only might be related to anterior-posterior position of the tooth 6 .
In 2007, a survey of Australian and New Zealand OMSs regarding their use of palatal injection was conducted by Badcock and McCullough 7 . The study was limited to extraction of maxillary third molars and the authors found that, in line with conventional teaching, palatal injection was widely used. However, they identified a small number of practitioners who do not always deliver the palatal injection (palatal injection delivered 'always': 77/84, 'most of the time': 4/84, 'occasionally': 2/84, 'never': 1/84).
Fifteen clinical trials (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) examining outcomes of maxillary tooth extractions performed with buccal injection of LA only, have been published, and were the subject of a recent review by Badenoch-Jones and Lincoln 8 . The included trials varied considerably in their designs and the authors gave the caveat that the results of each trial should be interpreted within the framework of the protocol of the particular study. Nevertheless, it was found that all nine controlled studies that assessed pain during the procedure failed to demonstrate a statistically significant difference between the test (buccal injection only) and control (buccal and palatal injection) groups. Four studies reported results according to region of the maxilla and provided some evidence for better M A N U S C R I P T
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results for anterior compared to posterior teeth, although none of the studies reported a P value for comparisons between the groups. The review authors made the point that the relevant consideration in clinical practice is the 'cost' versus benefit of the intervention (i.e. the pain of palatal injection versus the pain that it eliminates during the procedure), whereas, the majority of included trials considered only whether they was a benefit from the intervention.
The findings of the 2007 survey 7 and the review 7, 8 , together, raise the possibility that in some circumstances, the palatal injection might not be required. The purpose of the current study was to examine previously reported estimates for the percentage of practitioners who do not 'always' deliver a palatal injection, and by way of a similar survey improve on the sample size of the 2007 survey. We also aimed to expand on the previous research by collecting data for all regions of the maxilla in order to analyse for variance in results that might be due to the region.
Methods

Sample Size/Power Calculation
The results of Badcock and McCullough 7 for the proportion of practitioners who 'always' deliver a palatal injection for extraction of maxillary teeth were used to determine the sample size required for our study. Although the study by Badcock and McCullough 7 was limited to the extraction of maxillary third molar teeth, given the similarity expected for results across all maxillary teeth, this estimated sample size was used for our study. Our null hypothesis was that the proportion of practitioners who 'always' deliver a palatal injection for the extraction of maxillary teeth, as reported by Badcock and McCullough 7 is 0.92. Conversely, our alternative hypothesis was that the true population proportion is not 0.92.
According to our calculation, at a power of 80%, a significance level of 5%, and a proportion of interest that differed more than 10% from the null proportion of interest (0.92), 89 respondents were required for our study. The null proportion was obtained from the study by Badcock and McCullough 7 in which 77 of the 84 respondents 'always' delivered a palatal injection for M A N U S C R I P T
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extraction of maxillary third molars (compared to practitioners who do not 'always' deliver the palatal injection, i.e. they give it 'most of the time', 'occasionally' or 'never').
We conducted a one-sample proportions test to determine if there was a difference in the proportion of respondents that 'always' delivered a palatal injection for extraction of maxillary third molars in the study by Badcock and McCullough 7 and the proportion of respondents that 'always' delivered a palatal injection for extraction of third molars in the present study.
Questionnaire
In constructing our survey, we used the survey by Badcock and McCullough 7 (obtained from the authors) as a reference. Respondents were asked how often they administered a palatal injection for permanent maxillary extractions under local anaesthetic in each region of the maxilla, grouped as: incisors (central and lateral), canines, premolars, first and second molars, and third molars. For this question, the same format as that used by Badcock and McCullough was maintained so that the results of the present study could be pooled with those obtained by Badcock and McCullough (for third molars). For the remainder of the survey, we used similar questions to those of Badcock and McCullough, although we sought more detailed information from respondents for some questions..Respondents were also able to provide general comments at the conclusion of the survey.
Our online survey was distributed via email link by The Canadian Association of Oral and Maxillofacial Surgeons (CAOMS) to all active full members (276), followed by a reminder to nonresponders 3 weeks later. Members were advised that participation in the study was voluntary and that their response could not be identified.
Approval for the study was gained from The University of Queensland Dental Sciences Research Ethics Committee.
Results
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Ninety-two members responded to the survey (33%), although some respondents did not complete all of the survey components. The respondents had practised as qualified OMSs in Canada or overseas for an average of 19.3 (SD: 11.5) years full time equivalent.
The responses are shown in Tables 1-3 .
Table 1
A one-sample proportions test indicated no significant difference (p=0.52) between the proportion of respondents that 'always' delivered a palatal injection for third molars in the study With the addition of intravenous sedation, 16% (15/92) of practitioners administer the palatal injection 'more commonly', 12% (11/92) 'less commonly', while for 72% (66/92) there is no difference.
Table 2
Of the respondents who were influenced by patient anxiety level in the delivery of the palatal injection, 69% (11/16) were 'more likely' to administer the injection for an anxious patient, while 31% (5/16) were 'less likely' to administer the injection for an anxious patient.
None of the respondents indicated that there were any additional factors, not included in the survey, which influence whether or not they administer a palatal injection (aside from tooth eruption status which we consider to fall under our category, pre-operative assessment: tooth/alveolar anatomy). One respondent commented that they administer a high posterior superior alveolar nerve block and that this usually achieves palatal anaesthesia. Table 3 The gauge of needles used by respondents to reduce the discomfort of palatal injection ranged from 25 to 33 (median: 30).
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Other techniques employed to reduce the discomfort of palatal injection that were not included in the survey but which are utilized by respondents were: -nitrous oxide (1 respondent) -intraligamentary and/or intrapapillary injection prior to palatal injection (2 respondents)
One respondent provided the comment that the techniques he/she uses to reduce the discomfort of palatal injection are not used for every patient. It is likely that this is the case for other respondents as well.
Discussion and Conclusion
Discussion of Results
In order to maximize the response rate, the authors aimed to keep the survey concise, and therefore collected only the data most relevant to answering the research question. As such, there was no aim to assess the independent effect of covariates such as geographical location, age, and gender, etc. Further, as the survey was completed on the basis of self-report and only given once, it was not possible to evaluate reliability metrics such as intra-rater and inter-rater reliability.
Limitations of the study include the possibility of non-response bias (difference in the estimate provided by the respondents vs the population estimate). No comparison between responders and non-responders was possible, as the research team was unable to collect covariate M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
information from the non-responders. We note that surveys of professionals (especially health professionals) generally have low response rates, with rates less than 33% not uncommon.
Further, a low response rate does not necessarily impart substantial bias(es), as the survey was not of the general population but rather of a specific target population that is more homogenous. 9 There is also the possibility of response bias, which occurs when respondents do not provide accurate responses. The particular type of survey and the population of respondents do not make this survey vulnerable to this type of bias, and further, we avoided yes/no answers, instead using the following options: 'always', 'most of the time', 'occasionally' and 'never'.
It is the view of this research team that the utilized one-page questionnaire has face validity (i.e. It is interesting to note the inconsistency in use of palatal injection for patients whom the practitioner judges to be anxious. Presumably, the practitioners who are 'more likely ' to administer the palatal injection for these patients do so to reduce pain during the procedure, while those practitioners who are 'less likely' to administer the palatal injection for these patients do so to avoid the pain of injection. At the crux of this inconsistency appears to be uncertainty over the relative cost (i.e. pain of palatal injection) and benefit (i.e. pain that it eliminates during the procedure) of the intervention (i.e. palatal injection). The former group of practitioners must believe that the benefit outweighs the cost, while the latter group must M A N U S C R I P T
believe that the cost outweighs the benefit. As mentioned earlier, the authors of the aforementioned systematic review 8 highlighted that the majority of clinical trails on the topic addressed only the benefit of the intervention, and not the cost; therefore, available evidence for cost versus benefit is sparse (the two trials where cost versus benefit was reported or could be calculated found that cost outweighed the benefit).
The results suggest that the factors which influence whether or not a palatal injection is administered by a surgeon vary according to the individual practitioner (only 14-40% are influenced by each factor). By contrast, there is greater consistency among practitioners in the techniques employed to reduce the discomfort of palatal injection (either uncommonly used (0-3%) or relatively commonly used (62-72%)).
Notwithstanding the nine-year difference in the dates of data collection (and the possibility of changing practice with time), the concordance of the results for third molars reported by Badcock and McCullough 7 , and in the present study (p=0.52), indicates similar practice in Australia/New Zealand and Canada. This is likely to be the case for other western countries as well.
While the results of this survey provide some additional evidence regarding the use of palatal injection for maxillary tooth extractions, data are still limited. Building on the current evidence with appropriately designed and executed trials will be necessary. Points to be addressed include the cost of the intervention, and trends in results according to region of the maxilla (to date, no trial has presented results according to region of the maxilla appropriately, i.e. with P values comparing groups).
Ideal Study Design
The following are our suggestions for further trials to address the identified gaps in knowledge: M A N U S C R I P T
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-Double blinded randomised controlled trials with large cohorts using saline palatal injection as the control.
-Inclusion of all maxillary teeth, grouped as: incisors (central and lateral), canine, premolars, first and second molars, third molars. Results of groups compared with appropriate statistics.
-Lignocaine hydrochloride or articaine hydrochloride standard dose for both buccal injection/s and palatal injection/s.
-Procedure 5 minutes after delivery of LA. For cases of failed initial anaesthesia, supplemental buccal injection, and if unsuccessful after 5 minutes, supplemental palatal injection.
-Unsuccessful anaesthesia determined by pain during the procedure, rather than by probing of the mucosa (the former directly addresses the research question). Table 1 . Number (%) of respondents: how often a palatal injection is administered for maxillary tooth extractions under LA according to region of the maxilla.
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